Hospital Haroldo Juaçaba

What Hospital Haroldo Juaçaba does

Hospital Haroldo Juaçaba is a private, multi-specialty hospital complex headquartered in Fortaleza, Ceará, Brazil, operating as part of the Grupo ICC Saúde network. Founded in 2011 through the rebranding of Hospital do Câncer, the institution traces its operating history to the Instituto do Câncer do Ceará established in 1944. The hospital functions as a regional reference center for oncology in the North-Northeast region of Brazil, offering more than 30 medical specialties, 160+ specialists, and a dedicated oncology care line (Linha de Cuidado) that integrates surgery, chemotherapy, radiotherapy, palliative care, and psychological and nutritional support. Its Centro de Radioterapia houses six linear accelerators — the third-largest radiotherapy hub in Brazil — and supports advanced techniques including radiosurgery, IGRT with cone-beam CT, and volumetric modulated arc therapy.

The technology stack pairs IBM Watson for Oncology (AI-driven therapeutic decision support) with ICC Genômica (precision medicine and genetic screening), the WeCancer remote patient monitoring application, and the AnaeSight surgical monitoring platform for BIS-based anesthesia delivery. The recently added robotic surgery capability and the 2025-repositioned Executive Check-up program (40+ exams in ~7 hours) extend the service surface into higher-margin premium and preventive care. The hospital integrates with external diagnostic platforms (Lisnet, Pixeon Clickvita) and operates the ICC BioLabs innovation hub supporting healthcare startups.

Revenue is generated through a mixed payor model: SUS (the Brazilian public health system, for which the hospital is a designated oncology and high-complexity reference center), 25+ private health insurance operators (convênios), direct private-pay patients, telemedicine consultations (teleconsultas from R$100), and diagnostic and laboratory services. Distribution is conducted via a central phone scheduling line, online patient portals, walk-in consultations, and partnership channels with both public and private payors. Strategic capital has been supported by PRONON and the Ministry of Health (R$15M radiotherapy investment) alongside an active research alliance with IBM and Harvard University on AI in oncology.

Name

Hospital Haroldo Juaçaba

Legal name

Hospital Haroldo Juaçaba

Website

https://haroldojuacaba.com.br

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Hospital Haroldo Juaçaba is a private multi-specialty hospital in Fortaleza, Brazil, and part of Grupo ICC Saúde, serving as the North-Northeast region's reference oncology center with 30+ specialties, 160+ specialists, and Brazil's third-largest radiotherapy hub (six linear accelerators). It serves SUS, 25+ health insurers, and private patients.

Ownership category

akta.pro rank

Product category

Specialty Hospital Services — Oncology

NAICS

General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

International/Medical Tourism Hospital Systems (HLAFAAAN)

Keywords

• Oncology treatment
• Hospital healthcare
• Radiotherapy services
• Diagnostic imaging
• Specialty medicine

Headquarters

HQ city

Fortaleza

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Health Insurance (Convênios): The hospital serves patients covered by more than 25 health insurance operators. Revenue is generated through insurance reimbursements for consultations, procedures, hospitalizations, and treatments.
2. SUS (Public Health System): As a reference hospital in oncology and high complexity care, the hospital receives funding from the Brazilian public health system (SUS) for services provided to public patients, including surgeries, chemotherapy, and radiotherapy.
3. Private Consultations and Procedures: Revenue from private patients (particular) paying for consultations, exams, and medical procedures not covered by insurance.
4. Telemedicine/Teleconsulta Services: Teleconsulta services offered during the pandemic and continued, with consultations starting from R$ 100.00, providing accessible remote medical care.
5. Diagnostic Services: Laboratory analyses, diagnostic imaging, pathological anatomy, and molecular biology services generating revenue from both institutional and external patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Hospital Haroldo Juaçaba is a private multi-specialty hospital complex in Fortaleza, Ceará, Brazil, providing oncology-focused inpatient and outpatient care through dedicated centers for specialties, diagnostics, radiotherapy, oncology, and specialized emergency care. Its offering includes oncology treatment (chemotherapy, radiotherapy, and surgery), robotic surgery, diagnostic imaging and laboratory services, 30+ medical specialty consultations, an executive health check-up program, and telemedicine, serving SUS, private health insurance, and self-pay patients across North-Northeast Brazil.

Differentiator

Problem solved

Functional benefit

Brands

• Centro de Especialidades: Specialty center offering more than 30 medical specialties.
• Centro Oncológico
• Centro de Radioterapia
• Centro de Diagnóstico
• Pronto Atendimento Especializado (PAE)

Products and services

• Centro Oncológico Haroldo Juaçaba Specialized oncology center providing comprehensive cancer care for oncology patients, with multidisciplinary diagnosis, surgical treatment, chemotherapy, radiotherapy, and follow-up delivered through an exclusive Linha de Cuidado (Care Line) model.
• Centro de Radioterapia Radiotherapy center equipped with six linear accelerators offering radiosurgery, IGRT with cone-beam CT, volumetric modulated arc therapy (VMAT), and hypofractionation for prostate tumors; the third largest radiotherapy center in Brazil.
• Centro de Diagnóstico Comprehensive diagnostic center providing clinical laboratory tests, pathological anatomy, molecular biology laboratory, radiology and diagnostic imaging, nuclear medicine, and video diagnostics for patients and referring physicians.
• Centro de Especialidades Multi-specialty center offering consultations and exams across more than 30 medical specialties for insurance and private patients, with units at the main complex and at the Unidade Aldeota location.
• Pronto Atendimento Especializado (PAE) Specialized emergency care unit providing immediate medical attention for urgent health conditions within the hospital complex.
• Check-up Executivo Executive health check-up program repositioned as a strategic health and longevity management tool, integrating over 40 exams, specialist consultations, and ICC Genômica genetic analysis, with results delivered within 48 hours.
• Teleconsultas (Telemedicine) Telemedicine service providing remote medical consultations across multiple specialties, especially oncology, with consultations starting from R$ 100.00 per session.
• ICC Genômica Specialized precision medicine and genomics nucleus within Rede ICC Saúde that identifies genetic predispositions to diseases before symptoms appear for prevention and monitoring, integrated into the hospital's Executive Check-up program.
• AnaeSight Surgical Monitoring Platform Anesthesia delivery and monitoring platform integrating real-time BIS brain-activity monitoring, physiological parameters, and anesthetic drug infusion for more individualized, safer, and efficient anesthesia administration during surgical procedures.
• WeCancer Remote Patient Monitoring Remote patient monitoring service used by the Centro Oncológico, connecting oncology patients with their multidisciplinary care team through daily symptom reporting and chat-based professional support.

Quantifiable outcome

• Leader in surgeries performed in Ceará with 4,998 elective surgeries in 2023
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• IBMcoreTechnology or IntegrationStrategic alliance between ICC/Hospital Haroldo Juaçaba and IBM for artificial intelligence research in oncology. IBM brought its global research leadership to ICC in a mission of great impact on global health. The partnership focuses on Watson for Oncology AI system adoption and new research studies on AI's influence on decision-making processes and patient clinical outcomes.
• Harvard UniversitycoreStrategic or Co-development PartnerInternational alliance between ICC/Hospital Haroldo Juaçaba, Harvard University, and IBM for oncological research with focus on treatment equity and AI applications in cancer care. A multiprofessional team of doctors, pharmacists, researchers, and statisticians actively participates in investigating AI's influence on therapeutic decision-making and patient outcomes.
• Rede ICC SaúdecoreStrategic or Co-development PartnerHospital Haroldo Juaçaba is an integral part of Rede ICC Saúde (ICC Health Network), which includes ICC BioLabs innovation hub, ICC Genômica, and multiple healthcare facilities. The network provides integrated research, teaching, innovation, and specialized healthcare services.
• Conselho Regional de Medicina do Ceará (CREMEC)minorStrategic or Co-development PartnerFormal partnership for medical ethics oversight. The hospital inaugurates its Medical Ethics Commission at CREMEC, conducted by CREMEC President Inês Tavares Vale e Melo and Vice-President Helvécio Neves Feitosa.
• ICC BioLabs Startups and PartnersminorOthersICC BioLabs accelerator program supporting health innovation startups including Phonoestheto (cardiology stethoscope technology), Olho Humano (precise biopsy technology), 4Wbiotech (cosmetic with healing/antiviral action), and Biocheminova (pharmaceutical efficacy testing without animal testing). Created in 2017 with 250m² physical space.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hospital de Câncer de Barretos: High-volume oncology hospital serving SUS and private patients, with a strong research and prevention focus across Brazil. Comparable as a leading Brazilian oncology hospital with significant public-payor case mix and reference-center status in its region.
• Oncoclínicas Group: Largest oncology-focused medical group in Latin America operating clinics and infusion centers across Brazil. Comparable as a multi-site oncology services competitor targeting similar private payors and patients in the Brazilian oncology market.
• A.C. Camargo Cancer Center: Dedicated oncology hospital in São Paulo combining treatment, research, and teaching, with a national referral base. Directly comparable as a specialty oncology center with research partnerships, advanced radiotherapy, and academic orientation.

Regional players

• Hospital do Câncer de Pernambuco (HCP): Major oncology hospital in Recife serving the Pernambuco and broader Northeast region of Brazil. Most directly comparable as a regional Northeast oncology reference center that could compete with HHJ for North-Northeast referrals.

Broad incumbents

• Rede D'Or São Luiz: Largest private hospital network in Brazil with extensive oncology, cardiology, and multi-specialty coverage across multiple states. Comparable as a scaled multi-site Brazilian private hospital operator with diversified payor exposure.
• Hospital Israelita Albert Einstein: One of Latin America's leading private hospital systems, based in São Paulo, offering comprehensive multi-specialty care with strong oncology programs. Comparable as a premium Brazilian private hospital network with diversified payor mix and academic affiliations.
• Hospital Santa Catarina: Established São Paulo private hospital with broad multi-specialty services including oncology, serving both private payors and SUS. Comparable as a Brazilian private hospital of similar scale competing for premium-payor contracts.
• Hospital Moinhos de Vento: Leading non-profit private hospital in Porto Alegre with strong oncology and multi-specialty capabilities, Johns Hopkins affiliate. Comparable as a high-acuity Brazilian hospital pursuing academic partnerships and advanced specialty care.
• Hospital Sírio-Libanês: Elite São Paulo-based private hospital with a national referral footprint in oncology, complex surgery, and precision medicine. Comparable as a high-acuity private tertiary hospital competing for the same complex-case referrals from across Brazil.
• Hospital Alemão Oswaldo Cruz: Major São Paulo-based private hospital known for oncology, complex surgery, and translational research. Comparable as a premium Brazilian private hospital with academic research ties and advanced specialty programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/haroldojuacaba

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospital Haroldo Juaçaba